Physician profile
Alexander Saunders
NPI 1669099263
$1,773.41
in general payments reported to CMS, 2019-2025
18 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $434 · 2022: $323 · 2023: $417 · 2024: $341 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $246.53 | 2022-2024 | Acthar |
| Sight Sciences, INC. | $241.86 | 2022-2025 | Tearcare System, Omni Surgical System |
| Ivantis, INC | $163.46 | 2021 | |
| Biotissue Holdings INC. | $155.71 | 2023-2025 | |
| New World Medical,INC. | $135.51 | 2023 | |
| Alcon Vision LLC | $126.36 | 2021-2023 | Total30 |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| Allergan, INC. | $107.86 | 2021 | |
| Sun Pharmaceutical Industries INC. | $102.76 | 2023-2024 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $88.11 | 2023-2024 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Abbvie INC. | $87.06 | 2022-2024 | Lumigan, Alphagan P, Vuity |
| Oyster Point Pharma, INC. | $48.08 | 2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $35.07 | 2024 | Xdemvy |
| Coopervision INC. | $23.99 | 2022 | |
| Ocular Therapeutix, INC. | $23.66 | 2023 | Dextenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $22.41 | 2025 | Vabysmo |
| Glaukos Corporation | $20.34 | 2021 | |
| Harrow Eye, LLC | $19.64 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.